Conference Report

Highlights in Viral Hepatitis: CCO Independent Conference Report on the 2007 Digestive Disease Week

Source: CCO Independent Conference Coverage of the 2007 Digestive Disease Week*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Highlights in Viral Hepatitis: CCO Independent Conference Report on the 2007 Digestive Disease Week

Faculty:

Mark S. Sulkowski, MD
Kris V. Kowdley, MD, FACP

CME CREDIT INFORMATION

Release Date: 07/30/07

Expiration Date: 07/29/08

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the results of recent studies of diagnostic tests for viral hepatitis and its complications, including fibrosis, cirrhosis, and hepatocellular carcinoma
Discuss the use of FDA-approved agents for the treatment of patients with chronic hepatitis B or chronic hepatitis C and strategies for managing their adverse effects
Discuss results of clinical studies of investigational treatments for chronic hepatitis B and C

Topics covered include:

14-Day R1626 Monotherapy in Treatment-Naive Hepatitis C Virus Genotype 1 Patients
14-Day HCV-796 Monotherapy in Treatment-Naive HCV Patients
Pancaspase Inhibitor PF-03491390
Impact of Predosing of Taribavirin on Sustained Virologic Response Rates
Rosuvastatin Therapy Does Not Impact HCV RNA Levels
Retreatment of Patients Who Do Not Achieve SVR With Peginterferon and Ribavirin Therapy
Impact of HCV Therapy With or Without SVR on Liver Histology
HCV-Positive and -Negative Hepatic Transplantations Into HCV-Positive Patients
Implementation of HCV Therapy in a Real-World Setting
Darbepoetin Alfa and Filgrastim Treatments for Cytopenias
Natural History of Hepatitis B
Treatments for Chronic Hepatitis B
Prophylactic Use of Lamivudine During Chemotherapy

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.